{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:14:40Z","timestamp":1781100880868,"version":"3.54.1"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Autoimmune hepatitis (AIH)\u2013primary biliary cirrhosis (PBC) overlap syndrome (OS) is a vaguely defined entity demonstrating features of AIH and PBC. We investigated the usefulness of IgG and IgM immunostaining for the distinction of AIH and PBC and their staining pattern in cases of possible OS. The approximate quantity of IgG+ and IgM+ periportal inflammatory cells in immunohistochemical analysis were compared in cases of AIH, PBC, and OS. AIH cases showed predominant IgG immunostaining of periportal inflammatory cells. A significant number of PBC cases also demonstrated IgG predominance rather than IgM. Six OS cases had IgG predominance, 4 had IgM predominance, and 1 was equivocal. The usefulness of IgG and IgM immunostaining is limited in PBC cases with IgM predominance for excluding AIH. IgG predominance is not specific for AIH. OS does not demonstrate either IgG or IgM predominance (P &amp;gt; .2) and does not help classify OS into either category.<\/jats:p>","DOI":"10.1309\/ajcpe93gzshuntai","type":"journal-article","created":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T21:03:15Z","timestamp":1266008595000},"page":"430-437","source":"Crossref","is-referenced-by-count":28,"title":["The Usefulness of IgG and IgM Immunostaining of Periportal Inflammatory Cells (Plasma Cells and Lymphocytes) for the Distinction of Autoimmune Hepatitis and Primary Biliary Cirrhosis and Their Staining Pattern in Autoimmune Hepatitis\u2013Primary Biliary Cirrhosis Overlap Syndrome"],"prefix":"10.1093","volume":"133","author":[{"given":"Hwajeong","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Henry Ford Hospital, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Stapp","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Henry Ford Hospital, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian H.","family":"Ormsby","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Henry Ford Hospital, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena V.","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Henry Ford Hospital, Detroit, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,3,1]]},"reference":[{"key":"2023011906250268100_b1-1330430","first-page":"79","article-title":"Diagnostic and therapeutic questions in overlap syndromes of autoimmune hepatitis","volume":"53","author":"Premoli","year":"2007","journal-title":"Minerva Gastroenterol Dietol"},{"key":"2023011906250268100_b2-1330430","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis\u2013autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"key":"2023011906250268100_b3-1330430","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"key":"2023011906250268100_b4-1330430","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0025-6196(11)63653-7","article-title":"Autoimmune cholangitis: a unique entity?","volume":"73","author":"Sherlock","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"2023011906250268100_b5-1330430","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"2023011906250268100_b6-1330430","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1089-3261(02)00007-7","article-title":"Autoimmune hepatitis and overlap syndromes","volume":"6","author":"Dienes","year":"2002","journal-title":"Clin Liver Dis"},{"key":"2023011906250268100_b7-1330430","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","article-title":"Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals","volume":"29","author":"Lohse","year":"1999","journal-title":"Hepatology"},{"key":"2023011906250268100_b8-1330430","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2005-916322","article-title":"Overlap syndromes","volume":"25","author":"Beuers","year":"2005","journal-title":"Semin Liver Dis"},{"key":"2023011906250268100_b9-1330430","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","article-title":"Long term outcome and response to therapy of primary biliary cirrhosis\u2013autoimmune hepatitis overlap syndrome","volume":"44","author":"Chazouill\u00e8res","year":"2006","journal-title":"J Hepatol"},{"key":"2023011906250268100_b10-1330430","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1309\/AJCP8WHR0IEVUUOJ","article-title":"Immunostaining of plasma cells in primary biliary cirrhosis","volume":"131","author":"Daniels","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"2023011906250268100_b11-1330430","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histologic grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"2023011906250268100_b12-1330430","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0016-5085(76)80453-2","article-title":"Responses to treatment can differentiate chronic active liver disease with cholangitic features from primary biliary cirrhosis syndrome","volume":"71","author":"Guebel","year":"1976","journal-title":"Gastroenterology"},{"issue":"suppl","key":"2023011906250268100_b13-1330430","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.jhep.2004.11.009","article-title":"Hepatic overlap syndromes","volume":"42","author":"Beuers","year":"2005","journal-title":"J Hepatol"},{"key":"2023011906250268100_b14-1330430","first-page":"1949","article-title":"Autoimmune cholangitis: case report","volume":"46","author":"Marinho","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"2023011906250268100_b15-1330430","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/gut.35.2.260","article-title":"Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis","volume":"35","author":"Michieletti","year":"1994","journal-title":"Gut"},{"key":"2023011906250268100_b16-1330430","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hep.1840180103","article-title":"Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis","volume":"18","author":"Ben-Ari","year":"1993","journal-title":"Hepatology"},{"issue":"suppl 1","key":"2023011906250268100_b17-1330430","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1038\/modpathol.3800684","article-title":"Autoimmune liver disease: overlap and outliers","volume":"20","author":"Washington","year":"2007","journal-title":"Mod Pathol"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/133\/3\/430\/48763295\/ajcp_133_3_430.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/133\/3\/430\/48763295\/ajcp_133_3_430.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T06:25:50Z","timestamp":1674109550000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/133\/3\/430\/1766134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,1]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,3,1]]},"published-print":{"date-parts":[[2010,3,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpe93gzshuntai","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,3,1]]},"published":{"date-parts":[[2010,3,1]]}}}